WO2001076451A3 - Diagnosis of diseases associated with metabolism - Google Patents
Diagnosis of diseases associated with metabolism Download PDFInfo
- Publication number
- WO2001076451A3 WO2001076451A3 PCT/EP2001/004016 EP0104016W WO0176451A3 WO 2001076451 A3 WO2001076451 A3 WO 2001076451A3 EP 0104016 W EP0104016 W EP 0104016W WO 0176451 A3 WO0176451 A3 WO 0176451A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- metabolism
- genes associated
- diagnosis
- diseases associated
- oligonuecleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/240,454 US20040067491A1 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with metabolism |
AU2001277487A AU2001277487A1 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with metabolism |
EP01955278A EP1360319A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with metabolism |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10019058A DE10019058A1 (en) | 2000-04-06 | 2000-04-06 | Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle |
DE10019058.8 | 2000-04-06 | ||
DE10019173 | 2000-04-07 | ||
DE10019173.8 | 2000-04-07 | ||
DE10032529A DE10032529A1 (en) | 2000-06-30 | 2000-06-30 | Diagnosis of major genetic parameters within the Major Histocompatibility Complex (MHC) |
DE10032529.7 | 2000-06-30 | ||
DE10043826 | 2000-09-01 | ||
DE10043826.1 | 2000-09-01 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001076451A2 WO2001076451A2 (en) | 2001-10-18 |
WO2001076451A9 WO2001076451A9 (en) | 2002-08-08 |
WO2001076451A3 true WO2001076451A3 (en) | 2003-09-04 |
Family
ID=27437807
Family Applications (8)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/004016 WO2001076451A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with metabolism |
PCT/EP2001/004015 WO2001077378A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with dna adducts |
PCT/EP2001/003971 WO2001077377A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with dna replication by assessing dna methylation |
PCT/EP2001/003970 WO2001077376A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with metastasis |
PCT/EP2001/003969 WO2001077164A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
PCT/EP2001/003968 WO2001077375A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with gene regulation |
PCT/EP2001/003972 WO2001081622A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with dna repair |
PCT/EP2001/003973 WO2001092565A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
Family Applications After (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/004015 WO2001077378A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with dna adducts |
PCT/EP2001/003971 WO2001077377A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with dna replication by assessing dna methylation |
PCT/EP2001/003970 WO2001077376A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with metastasis |
PCT/EP2001/003969 WO2001077164A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
PCT/EP2001/003968 WO2001077375A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with gene regulation |
PCT/EP2001/003972 WO2001081622A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated with dna repair |
PCT/EP2001/003973 WO2001092565A2 (en) | 2000-04-06 | 2001-04-06 | Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
Country Status (7)
Country | Link |
---|---|
US (7) | US20030148326A1 (en) |
EP (9) | EP1278893A2 (en) |
JP (3) | JP2003534780A (en) |
AT (1) | ATE353975T1 (en) |
AU (9) | AU2001275663A1 (en) |
DE (1) | DE60126593T2 (en) |
WO (8) | WO2001076451A2 (en) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6780982B2 (en) * | 1996-07-12 | 2004-08-24 | Third Wave Technologies, Inc. | Charge tags and the separation of nucleic acid molecules |
US6818404B2 (en) | 1997-10-23 | 2004-11-16 | Exact Sciences Corporation | Methods for detecting hypermethylated nucleic acid in heterogeneous biological samples |
US7582420B2 (en) | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
US7955794B2 (en) | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
US8076063B2 (en) | 2000-02-07 | 2011-12-13 | Illumina, Inc. | Multiplexed methylation detection methods |
EP1278893A2 (en) | 2000-04-06 | 2003-01-29 | Epigenomics AG | Diagnosis of diseases associated with dna replication |
WO2001093902A2 (en) * | 2000-06-07 | 2001-12-13 | Biosynexus Incorporated | Immunostimulatory rna/dna hybrid molecules |
US20040023230A1 (en) * | 2000-06-30 | 2004-02-05 | Alexander Olek | Method and nucleic acids for pharmacogenomic methylation analysis |
AUPR142500A0 (en) * | 2000-11-13 | 2000-12-07 | Human Genetic Signatures Pty Ltd | A peptide nucleic acid-based assay for the detection of specific nucleic acid sequences |
DE10128508A1 (en) | 2001-06-14 | 2003-02-06 | Epigenomics Ag | Methods and nucleic acids for the differentiation of prostate tumors |
US7432050B2 (en) | 2001-10-05 | 2008-10-07 | Case Western Reserve University | Methods and compositions for detecting colon cancers |
JP2003144172A (en) * | 2001-11-16 | 2003-05-20 | Nisshinbo Ind Inc | Oligonucleotide-immobilized board for detecting methylation |
US20110151438A9 (en) * | 2001-11-19 | 2011-06-23 | Affymetrix, Inc. | Methods of Analysis of Methylation |
DE10161625A1 (en) * | 2001-12-14 | 2003-07-10 | Epigenomics Ag | Methods and nucleic acids for the analysis of a pulmonary cell division disorder |
WO2003076593A2 (en) | 2002-03-07 | 2003-09-18 | The Johns Hopkins University School Of Medicine | Genomic screen for epigenetically silenced genes associated with cancer |
EP1344832A1 (en) * | 2002-03-15 | 2003-09-17 | Epigenomics AG | Methods and nucleic acids for the analysis of methylation within the gene melastatin |
AU2003225983A1 (en) * | 2002-03-25 | 2003-10-13 | St. Jude Children's Research Hospital | Cpg retrieval of dna from formalin-fixed pathology specimen for promoter methylation analysis |
EP1551221A4 (en) * | 2002-07-03 | 2007-08-01 | Coley Pharm Group Inc | Nucleic acid compositions for stimulating immune responses |
US20040053880A1 (en) | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US7807803B2 (en) | 2002-07-03 | 2010-10-05 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
EP1554407B1 (en) * | 2002-10-01 | 2009-07-29 | Epigenomics AG | Method for the treatment of breast cell proliferative disorders |
US20060094016A1 (en) * | 2002-12-02 | 2006-05-04 | Niall Gormley | Determination of methylation of nucleic acid sequences |
DE10304219B3 (en) * | 2003-01-30 | 2004-08-19 | Epigenomics Ag | Method for the detection of cytosine methylation patterns with high sensitivity |
WO2004070062A2 (en) * | 2003-02-04 | 2004-08-19 | Wyeth | Compositions and methods for diagnosing and treating cancers |
US20050009059A1 (en) * | 2003-05-07 | 2005-01-13 | Affymetrix, Inc. | Analysis of methylation status using oligonucleotide arrays |
US7799525B2 (en) | 2003-06-17 | 2010-09-21 | Human Genetic Signatures Pty Ltd. | Methods for genome amplification |
US8415100B2 (en) | 2003-08-14 | 2013-04-09 | Case Western Reserve University | Methods and compositions for detecting gastrointestinal and other cancers |
EP1660683B1 (en) * | 2003-08-14 | 2017-04-19 | Case Western Reserve University | Methods and compositions for detecting colon cancers |
DE10338308B4 (en) | 2003-08-15 | 2006-10-19 | Epigenomics Ag | Method for the detection of cytosine methylations in DNA |
ATE419394T1 (en) | 2003-09-04 | 2009-01-15 | Human Genetic Signatures Pty | NUCLEIC ACID DETECTION TEST |
EP1689885B1 (en) * | 2003-10-20 | 2012-10-17 | St Vincent's Hospital Sydney Limited | Assessment of predisposition to cancer by quantitative determination of methylation in normal cells of healthy persons. |
EP3269826B1 (en) * | 2003-12-01 | 2020-03-11 | Epigenomics AG | Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders |
EP1561821B1 (en) | 2003-12-11 | 2011-02-16 | Epigenomics AG | Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients |
EP1568786A3 (en) * | 2004-02-13 | 2007-08-29 | Affymetrix, Inc. (A US Entity) | Analysis of methylation status using nucleic acid arrays |
US8168777B2 (en) | 2004-04-29 | 2012-05-01 | Human Genetic Signatures Pty. Ltd. | Bisulphite reagent treatment of nucleic acid |
CN101056883B (en) | 2004-09-10 | 2012-10-10 | 人类遗传标记控股有限公司 | Amplification blocker for intercalating nucleic acid (ina) containing intercalating pseudo nucleic acid (IPN) |
KR20060026595A (en) | 2004-09-21 | 2006-03-24 | (주)지노믹트리 | Method for detecting methylaion of promoter using restriction enzyme and dna chip |
KR100617649B1 (en) * | 2004-09-24 | 2006-09-04 | (주)지노믹트리 | Composition For Cancer diagnosis Containing Methylated Promoters of Colon Cancer Specific Expression-decreased Genes and Use Thereof |
CA2589668C (en) | 2004-12-03 | 2014-09-02 | Human Genetic Signatures Pty Ltd | Methods for simplifying microbial nucleic acids by chemical modification of cytosines |
US20060134650A1 (en) * | 2004-12-21 | 2006-06-22 | Illumina, Inc. | Methylation-sensitive restriction enzyme endonuclease method of whole genome methylation analysis |
WO2006088978A1 (en) | 2005-02-16 | 2006-08-24 | Epigenomics, Inc. | Method for determining the methylation pattern of a polynucleic acid |
JP5133238B2 (en) | 2005-04-15 | 2013-01-30 | エピゲノミックス アクチェンゲゼルシャフト | Method for providing a DNA fragment from a remote sample |
WO2006111586A2 (en) * | 2005-04-20 | 2006-10-26 | Proyecto De Biomedicina Cima, S.L. | Method for the in vitro determination of the degree of methylation of the line-1 promoter |
CN101203618B (en) | 2005-05-26 | 2013-03-13 | 人类遗传标记控股有限公司 | Isothermal strand displacement amplification using primers containing a non-regular base |
US20060292585A1 (en) * | 2005-06-24 | 2006-12-28 | Affymetrix, Inc. | Analysis of methylation using nucleic acid arrays |
US8343738B2 (en) | 2005-09-14 | 2013-01-01 | Human Genetic Signatures Pty. Ltd. | Assay for screening for potential cervical cancer |
NZ593228A (en) | 2006-01-11 | 2012-10-26 | Genomic Health Inc | Gene expression markers (inhba) for colorectal cancer prognosis |
US7465544B2 (en) * | 2006-01-11 | 2008-12-16 | Wisconsin Alumni Research Foundation | Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use |
EP1826279B1 (en) | 2006-02-28 | 2011-05-04 | Charité - Universitätsmedizin Berlin | Detection and quality control of regulatory T cells through DNA-methylation analysis of the FoxP3 gene |
US7901882B2 (en) * | 2006-03-31 | 2011-03-08 | Affymetrix, Inc. | Analysis of methylation using nucleic acid arrays |
EP2194143B1 (en) * | 2006-05-02 | 2016-06-29 | University of Southampton | Phenotype prediction |
US8084734B2 (en) * | 2006-05-26 | 2011-12-27 | The George Washington University | Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays |
WO2008096146A1 (en) | 2007-02-07 | 2008-08-14 | Solexa Limited | Preparation of templates for methylation analysis |
RU2565540C2 (en) * | 2007-10-23 | 2015-10-20 | Клиникал Джиномикс Пти. Лтд. | Method of diagnosing neoplasm-ii |
JP5431351B2 (en) | 2007-11-27 | 2014-03-05 | ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド | Enzymes for amplifying and copying bisulfite modified nucleic acids |
US9670546B2 (en) | 2008-07-15 | 2017-06-06 | Epigenomics Ag | Methods and nucleic acids for analyses of cell proliferative disorders |
EP2340314B8 (en) * | 2008-10-22 | 2015-02-18 | Illumina, Inc. | Preservation of information related to genomic dna methylation |
US8110796B2 (en) | 2009-01-17 | 2012-02-07 | The George Washington University | Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays |
US9490113B2 (en) * | 2009-04-07 | 2016-11-08 | The George Washington University | Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry |
SG175832A1 (en) | 2009-05-01 | 2011-12-29 | Genomic Health Inc | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy |
US20120322670A1 (en) | 2009-08-28 | 2012-12-20 | Cellular Dynamics International, Inc. | Identifying genetic variation in affected tissues |
US20130195884A1 (en) * | 2009-12-31 | 2013-08-01 | Deutsches Krebsforschungszentrum | Novel modulators of trail signalling |
EP2702177B1 (en) * | 2011-04-28 | 2017-04-12 | New York University | Genomic signatures of metastasis in prostate cancer |
US10435743B2 (en) | 2011-05-20 | 2019-10-08 | The Regents Of The University Of California | Method to estimate age of individual based on epigenetic markers in biological sample |
MX350658B (en) | 2011-09-07 | 2017-09-13 | Human Genetic Signatures Pty Ltd | Molecular detection assay. |
EP2821487B1 (en) * | 2012-02-29 | 2016-10-26 | Sysmex Corporation | Method for determining presence or absence of cancer cell derived from hepatocellular carcinoma, and determination marker and kit |
US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
KR101302173B1 (en) | 2012-12-07 | 2013-08-30 | 이화여자대학교 산학협력단 | Composition for diagnosing alzheimer's disease using methylation status of hmox1 gene and method for diagnosing alzheimer's disease using the same |
US20140274757A1 (en) | 2013-03-14 | 2014-09-18 | Marie K. Kirby | Differential Methylation Level of CpG Loci That Are Determinative of a Biochemical Reoccurrence of Prostate Cancer |
US20170051354A1 (en) * | 2014-04-28 | 2017-02-23 | Sigma-Aldrich Co. Llc | Epigenetic modification of mammalian genomes using targeted endonucleases |
EP3850083A4 (en) * | 2018-09-14 | 2022-06-29 | Shinozaki, Gen | Systems and methods for detection of delirium risk using epigenetic markers |
CN111217900A (en) * | 2018-11-27 | 2020-06-02 | 上海交通大学 | Transcription regulation factor for angiogenesis and application thereof |
SG11202107670TA (en) | 2019-01-18 | 2021-08-30 | Univ California | Dna methylation measurement for mammals based on conserved loci |
JP2022552400A (en) | 2019-10-14 | 2022-12-15 | ジェンキュリクス インク | COMPOSITION FOR DIAGNOSING LIVER CANCER USING CPG METHYLATION CHANGE IN SPECIFIC GENE AND USE THEREOF |
KR102637032B1 (en) | 2020-01-28 | 2024-02-15 | 주식회사 젠큐릭스 | Composition for diagnosing bladder cancer using CpG methylation status of specific gene and uses thereof |
WO2021206467A1 (en) | 2020-04-08 | 2021-10-14 | 주식회사 젠큐릭스 | Composition for diagnosing colorectal cancer, rectal cancer, or colorectal adenoma using cpg methylation change of glrb gene, and use thereof |
CN111500702B (en) * | 2020-04-26 | 2021-04-20 | 江苏大学附属医院 | Application of cg00843506 site methylation of RPN1 gene in diagnosing asthma |
WO2023175019A1 (en) | 2022-03-15 | 2023-09-21 | Genknowme S.A. | Method determining the difference between the biological age and the chronological age of a subject |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997046705A1 (en) * | 1996-06-03 | 1997-12-11 | The Johns Hopkins University School Of Medicine | Methylation specific detection |
US5744305A (en) * | 1989-06-07 | 1998-04-28 | Affymetrix, Inc. | Arrays of materials attached to a substrate |
WO1998056952A1 (en) * | 1997-06-09 | 1998-12-17 | University Of Southern California | A cancer diagnostic method based upon dna methylation differences |
WO1999028498A2 (en) * | 1997-11-27 | 1999-06-10 | Epigenomics Gmbh | Method for producing complex dna methylation fingerprints |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
SE501439C2 (en) | 1993-06-22 | 1995-02-13 | Pharmacia Lkb Biotech | Method and apparatus for analyzing polynucleotide sequences |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
WO1995011995A1 (en) * | 1993-10-26 | 1995-05-04 | Affymax Technologies N.V. | Arrays of nucleic acid probes on biological chips |
JPH09506253A (en) | 1993-11-30 | 1997-06-24 | マクギル・ユニヴァーシティ | Inhibition of DNA methyltransferase |
US5858661A (en) * | 1995-05-16 | 1999-01-12 | Ramot-University Authority For Applied Research And Industrial Development | Ataxia-telangiectasia gene and its genomic organization |
US5871917A (en) | 1996-05-31 | 1999-02-16 | North Shore University Hospital Research Corp. | Identification of differentially methylated and mutated nucleic acids |
DE19750172C1 (en) * | 1997-11-12 | 1998-10-01 | Deutsches Krebsforsch | DNA with promoter activity |
EP1036202B1 (en) * | 1997-12-05 | 2002-05-02 | Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. | Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry |
WO2000005419A1 (en) * | 1998-07-24 | 2000-02-03 | Yeda Research And Development Company Ltd. | Prevention of metastasis with 5-aza-2'-deoxycytidine |
DE19905082C1 (en) * | 1999-01-29 | 2000-05-18 | Epigenomics Gmbh | Identification of methylation patterns of cytosine in genome DNA comprises chemical treatment to produce different base pairing behavior between cytosine and 5-methylcytosine |
US6331393B1 (en) * | 1999-05-14 | 2001-12-18 | University Of Southern California | Process for high-throughput DNA methylation analysis |
US6783933B1 (en) * | 1999-09-15 | 2004-08-31 | The Johns Hopkins University School Of Medicine | CACNA1G polynucleotide, polypeptide and methods of use therefor |
US7332275B2 (en) * | 1999-10-13 | 2008-02-19 | Sequenom, Inc. | Methods for detecting methylated nucleotides |
JP2004507214A (en) | 2000-03-15 | 2004-03-11 | エピゲノミクス アーゲー | Diagnosis of tumor suppressor genes and diseases related to oncogenes |
EP1278893A2 (en) | 2000-04-06 | 2003-01-29 | Epigenomics AG | Diagnosis of diseases associated with dna replication |
US20040023230A1 (en) | 2000-06-30 | 2004-02-05 | Alexander Olek | Method and nucleic acids for pharmacogenomic methylation analysis |
DE10037769A1 (en) | 2000-08-03 | 2002-02-21 | Epigenomics Gmbh | Diagnosis of diseases associated with CD24 |
US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
DE10054972A1 (en) | 2000-11-06 | 2002-06-06 | Epigenomics Ag | Diagnosis of diseases associated with humus |
DE10054974A1 (en) | 2000-11-06 | 2002-06-06 | Epigenomics Ag | Diagnosis of diseases associated with Cdk4 |
DE10128508A1 (en) | 2001-06-14 | 2003-02-06 | Epigenomics Ag | Methods and nucleic acids for the differentiation of prostate tumors |
WO2003004696A2 (en) * | 2001-07-02 | 2003-01-16 | Epigenomics Ag | A distributed system for epigenetic based prediction of complex phenotypes |
-
2001
- 2001-04-06 EP EP01953145A patent/EP1278893A2/en not_active Withdrawn
- 2001-04-06 EP EP01953937A patent/EP1274866A2/en not_active Ceased
- 2001-04-06 AU AU2001275663A patent/AU2001275663A1/en not_active Abandoned
- 2001-04-06 EP EP01955278A patent/EP1360319A2/en not_active Withdrawn
- 2001-04-06 WO PCT/EP2001/004016 patent/WO2001076451A2/en not_active Application Discontinuation
- 2001-04-06 EP EP01969303A patent/EP1268861A2/en not_active Withdrawn
- 2001-04-06 AU AU7633001A patent/AU7633001A/en active Pending
- 2001-04-06 US US10/240,453 patent/US20030148326A1/en not_active Abandoned
- 2001-04-06 WO PCT/EP2001/004015 patent/WO2001077378A2/en not_active Application Discontinuation
- 2001-04-06 EP EP01956429A patent/EP1370685A2/en not_active Withdrawn
- 2001-04-06 DE DE60126593T patent/DE60126593T2/en not_active Expired - Fee Related
- 2001-04-06 US US10/239,676 patent/US7195870B2/en not_active Expired - Fee Related
- 2001-04-06 EP EP01953936A patent/EP1274865B1/en not_active Expired - Lifetime
- 2001-04-06 WO PCT/EP2001/003971 patent/WO2001077377A2/en not_active Application Discontinuation
- 2001-04-06 EP EP08012765A patent/EP2014776A3/en not_active Ceased
- 2001-04-06 AU AU2001276330A patent/AU2001276330B2/en not_active Ceased
- 2001-04-06 AT AT01953936T patent/ATE353975T1/en not_active IP Right Cessation
- 2001-04-06 WO PCT/EP2001/003970 patent/WO2001077376A2/en active Application Filing
- 2001-04-06 US US10/240,485 patent/US20030148327A1/en not_active Abandoned
- 2001-04-06 WO PCT/EP2001/003969 patent/WO2001077164A2/en active IP Right Grant
- 2001-04-06 AU AU2001289600A patent/AU2001289600A1/en not_active Abandoned
- 2001-04-06 WO PCT/EP2001/003968 patent/WO2001077375A2/en not_active Application Discontinuation
- 2001-04-06 EP EP01927895A patent/EP1272670A2/en not_active Withdrawn
- 2001-04-06 AU AU2001254794A patent/AU2001254794A1/en not_active Abandoned
- 2001-04-06 JP JP2001575230A patent/JP2003534780A/en not_active Withdrawn
- 2001-04-06 WO PCT/EP2001/003972 patent/WO2001081622A2/en active Application Filing
- 2001-04-06 US US10/240,589 patent/US20040076956A1/en not_active Abandoned
- 2001-04-06 JP JP2001575634A patent/JP2003531589A/en not_active Withdrawn
- 2001-04-06 AU AU2001278420A patent/AU2001278420A1/en not_active Abandoned
- 2001-04-06 AU AU2001254788A patent/AU2001254788A1/en not_active Abandoned
- 2001-04-06 US US10/240,708 patent/US20050282157A1/en not_active Abandoned
- 2001-04-06 AU AU2001276331A patent/AU2001276331A1/en not_active Abandoned
- 2001-04-06 WO PCT/EP2001/003973 patent/WO2001092565A2/en active Application Filing
- 2001-04-06 EP EP01927887A patent/EP1268857A2/en not_active Withdrawn
- 2001-04-06 AU AU2001277487A patent/AU2001277487A1/en not_active Abandoned
- 2001-04-06 US US10/240,454 patent/US20040067491A1/en not_active Abandoned
- 2001-04-06 US US10/240,452 patent/US20030162194A1/en not_active Abandoned
- 2001-04-06 JP JP2001575229A patent/JP2004508807A/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5744305A (en) * | 1989-06-07 | 1998-04-28 | Affymetrix, Inc. | Arrays of materials attached to a substrate |
WO1997046705A1 (en) * | 1996-06-03 | 1997-12-11 | The Johns Hopkins University School Of Medicine | Methylation specific detection |
WO1998056952A1 (en) * | 1997-06-09 | 1998-12-17 | University Of Southern California | A cancer diagnostic method based upon dna methylation differences |
WO1999028498A2 (en) * | 1997-11-27 | 1999-06-10 | Epigenomics Gmbh | Method for producing complex dna methylation fingerprints |
Non-Patent Citations (15)
Title |
---|
CROSS S.H. ET AL.: "Purification of CpG islands using a methylated DNA binding column", NATURE GENETICS, vol. 6, 1994, pages 236 - 244, XP002911234, DOI: doi:10.1038/ng0394-236 * |
DATABASE EBI [online] 18 October 1995 (1995-10-18), MACDONALD M. ET AL., XP002227176, Database accession no. Z56355 * |
DATABASE EBI [online] 20 July 1992 (1992-07-20), KANO M., XP002227074, Database accession no. D10500 * |
DATABASE EBI [online] BIRREN B. ET AL.: "Homo sapiens chromosome 11, clone RP11-56J3", XP002227073, Database accession no. AC015692 * |
DATABASE EBI [online] NAKAMURA Y., XP002227075, Database accession no. D83989 * |
DOTTORI M ET AL: "CLONING AND CHARACTERIZATION OF EPHA3 (HEK) GENE PROMOTER: DNA METHYLATION REGULATES EXPRESSION IN HEMATOPOIETIC TUMOR CELLS", BLOOD, W.B.SAUNDERS COMPAGNY, ORLANDO, FL, US, vol. 94, no. 7, 1999, pages 2477 - 2486, XP000907581, ISSN: 0006-4971 * |
ESTELLER MANEL ET AL: "Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 59, no. 4, 15 February 1999 (1999-02-15), pages 793 - 797, XP002182504, ISSN: 0008-5472 * |
HERMAN J G ET AL: "Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.", CANCER RESEARCH. UNITED STATES 15 FEB 1996, vol. 56, no. 4, 15 February 1996 (1996-02-15), pages 722 - 727, XP001120841, ISSN: 0008-5472 * |
HERMAN J G ET AL: "METHYLATION-SPECIFIC PCR: A NOVEL PCR ASSAY FOR METHYLATION STATUS OF CPG ISLANDS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, 1 September 1996 (1996-09-01), pages 9821 - 9826, XP002910406, ISSN: 0027-8424 * |
HUANG Y ET AL: "DECREASED EXPRESSION OF MANGANESE SUPEROXIDE DISMUTASE IN TRANSFORMED CELLS IS ASSOCIATED WITH INCREASED CYTOSINE METHYLATIONOF THE SOD2 GENE", DNA AND CELL BIOLOGY, NEW YORK, NY, US, vol. 18, no. 8, August 1999 (1999-08-01), pages 643 - 652-1592, XP000892711, ISSN: 1044-5498 * |
KANO M. ET AL.: "Structure and expression of the human mitochondrial acetoacetyl-CoA thiolase-encoding gene.", GENE, vol. 109, 1991, NL, pages 285 - 290, XP001121791 * |
MIKI Y. ET AL.: "Mutation analysis in the BRCA2 gene in primary breast cancers", NATURE GENETICS, vol. 13, 1996, pages 245 - 247 * |
MYÖHÄNEN S ET AL: "Automated fluorescent genomic sequencing as applied to the methylation analysis of the human ornithine decarboxylase gene.", DNA SEQUENCE: THE JOURNAL OF DNA SEQUENCING AND MAPPING. SWITZERLAND 1994, vol. 5, no. 1, 1994, pages 1 - 8, XP002227072, ISSN: 1042-5179 * |
STEINMETZ K L ET AL: "HYPOMETHYLATION OF THE RAT GLUTATHIONE S-TRANSFERASE PI (GSTP) PROMOTER REGION ISOLATED FROM METHYL-DEFICIENT LIVERS AND GSTP-POSITIVE LIVER NEOPLASMS", CARCINOGENESIS, XX, XX, vol. 19, no. 8, 1998, pages 1487 - 1494, XP002938224 * |
WISE THOMAS L ET AL: "The undermethylated state of a CpG island region in Igf2 transgenes is dependent on the H19 enhancers.", GENOMICS, vol. 60, no. 3, pages 258 - 271, XP002227071, ISSN: 0888-7543 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001076451A3 (en) | Diagnosis of diseases associated with metabolism | |
WO2001068911A8 (en) | Diagnosis of diseases associated with the cell cycle | |
WO2002002807A3 (en) | Diagnosis of diseases associated with cell signalling | |
WO2004035803A3 (en) | Method and nucleic acids for the treatment of breast cell proliferative disorders | |
WO2003052135A8 (en) | Method and nucleic acids for the analysis of a lung cell proliferative disorder | |
WO2002046454A3 (en) | Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis | |
WO2003014388A3 (en) | Method and nucleic acids for the analysis of colon cancer | |
WO2002036814A3 (en) | Diagnosis of diseases associated with cdk4 by determining the methylation state of the cdk4 | |
WO2002012554A3 (en) | Diagnosis of diseases which are associated with cd24 | |
AU2002214041A1 (en) | Diagnosis of diseases associated with the human c-mos gene | |
WO2001040521A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
WO2002103041A3 (en) | Method and nucleic acids for the differentiation of prostate and renal carcinomas | |
WO2001051670A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
WO2001038586A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
WO2001047942A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-17, DESCRIPTION, REPLACED BY NEW PAGES 1-19; PAGES 18-22, CLAIMS, REPLACED BY NEW PAGES 20-25; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001955278 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001277487 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10240454 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001955278 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001955278 Country of ref document: EP |